Docmode Health Technologies Ltd vs Jaro Institute Of Technol Mgt And Research Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Docmode Health Technologies Ltd is ₹ 44.1 as of 24 Apr 15:30 . The P/E Ratio of Docmode Health Technologies Ltd changed from 356.2 on March 2024 to 0 on March 2025 . This represents a CAGR of -100.00% over 2 yearsThe P/E Ratio of Jaro Institute of Technol. Mgt. and Research Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Docmode Health Technologies Ltd changed from ₹ 67.16 crore on March 2024 to ₹ 15.56 crore on March 2025 . This represents a CAGR of -51.87% over 2 yearsThe Market Cap of Jaro Institute of Technol. Mgt. and Research Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Docmode Health Technologies Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Jaro Institute of Technol. Mgt. and Research Ltd for the Dec '25 is ₹ 61.8 crore as compare to the Sep '25 revenue of ₹ 80.54 crore. This represent the decline of -23.27% The ebitda of Docmode Health Technologies Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Jaro Institute of Technol. Mgt. and Research Ltd for the Dec '25 is ₹ 12.29 crore as compare to the Sep '25 ebitda of ₹ 26.67 crore. This represent the decline of -53.92% The net profit of Docmode Health Technologies Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Jaro Institute of Technol. Mgt. and Research Ltd changed from ₹ 17.26 crore to ₹ 7.03 crore over 7 quarters. This represents a CAGR of -40.15% The Dividend Payout of Docmode Health Technologies Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Jaro Institute of Technol. Mgt. and Research Ltd changed from 3.92 % on March 2025 to 3.92 % on March 2025 . This represents a CAGR of 0.00% over 1 years .

About Docmode Health Technologies Ltd

Docmode Health Technologies Limited was incorporated on July 17, 2017 as a private limited Company with the Deputy Registrar of Companies Mumbai.
Thereafter, the Company was converted into a Public Limited Company and through effect in conversion of legal status dated January 2, 2023. DocMode is a pioneering healthcare technology company that is transforming the landscape of medical education, research, and practice.
With a vision to 'Transform Learning & Practice' in the medical fraternity, the Company has established itself as a leading provider of integrated learning solutions, cutting-edge practice tools, and comprehensive research platforms.
The Company is in the business of offering integrated learning solutions through online and offline learning model to Health care Professionals and learners across the world, spanning the education value chain.

About Jaro Institute of Technol. Mgt. and Research Ltd

Jaro Institute of Technology Management and Research Limited was originally incorporated as a Private Limited Company as 'Jaro Institute of Technology Management and Research Private Limited' on July 9, 2009, with the Registrar of Companies, Mumbai.
Thereafter, Company converted into a Public Limited and the name was changed to 'Jaro Institute of Technology Management and Research Limited', on August 12, 2017. Since the establishment of business in 2009 by Sanjay Namdeo Salunkhe, a first-generation entrepreneur, Company pioneered in the online higher education and Learning Management System.
At present, it is mainly engaged in facilitating student enrollments and program management services pertaining to the educational courses and degrees offered by the universities/institutes. The Company underwent amalgamation in FY 2016, when it merged with the erstwhile subsidiary, EINS Institute of Management Technology and Research Private Limited to strengthened Jaro's organizational framework.

FAQs for the comparison of Docmode Health Technologies Ltd and Jaro Institute of Technol. Mgt. and Research Ltd

Which company has a larger market capitalization, Docmode Health Technologies Ltd or Jaro Institute of Technol. Mgt. and Research Ltd?

Market cap of Docmode Health Technologies Ltd is 13 Cr while Market cap of Jaro Institute of Technol. Mgt. and Research Ltd is 970 Cr

What are the key factors driving the stock performance of Docmode Health Technologies Ltd and Jaro Institute of Technol. Mgt. and Research Ltd?

The stock performance of Docmode Health Technologies Ltd and Jaro Institute of Technol. Mgt. and Research Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Docmode Health Technologies Ltd and Jaro Institute of Technol. Mgt. and Research Ltd?

As of May 5, 2026, the Docmode Health Technologies Ltd stock price is INR ₹44.1. On the other hand, Jaro Institute of Technol. Mgt. and Research Ltd stock price is INR ₹437.75.

How do dividend payouts of Docmode Health Technologies Ltd and Jaro Institute of Technol. Mgt. and Research Ltd compare?

To compare the dividend payouts of Docmode Health Technologies Ltd and Jaro Institute of Technol. Mgt. and Research Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.